Two Sigma Securities’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,900
Closed -$743K 2158
2024
Q3
$743K Sell
10,900
-7,900
-42% -$446K 0.01% 1048
2024
Q2
$794K Buy
+18,800
New +$1.03M 0.01% 1212
2023
Q3
Sell
-6,400
Closed -$601K 3076
2023
Q2
$601K Sell
6,400
-1,600
-20% -$125K 0.01% 1312
2023
Q1
$542K Buy
+8,000
New +$514K 0.01% 1214
2022
Q3
Sell
-16,500
Closed -$650K 2743
2022
Q2
$650K Buy
16,500
+5,600
+51% +$299K 0.02% 734
2022
Q1
$762K Buy
+10,900
New +$797K 0.03% 750
2020
Q1
Sell
-16,100
Closed -$1.49M 1634
2019
Q4
$1.49M Buy
16,100
+10,300
+178% +$906K 0.01% 847
2019
Q3
$524K Sell
5,800
-2,000
-26% -$228K ﹤0.01% 1192
2019
Q2
$921K Buy
+7,800
New +$786K 0.01% 776
2019
Q1
Sell
-3,600
Closed -$227K 1977
2018
Q4
$227K Sell
3,600
-13,600
-79% -$933K ﹤0.01% 1614
2018
Q3
$1.36M Buy
17,200
+1,900
+12% +$124K 0.01% 900
2018
Q2
$915K Buy
15,300
+8,400
+122% +$452K ﹤0.01% 1398
2018
Q1
$278K Buy
+6,900
New +$337K ﹤0.01% 2057

Other funds holding EXAS

Two Sigma Securities's EXAS Position: Q3 2024 in Review

Two Sigma Securities sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 9,261 shares — an estimated $523K sold.

Two Sigma Securities first reported a position in EXAS in Q2 2017 and held it in 9 quarters. The position peaked at $1.27M in Q1 2024. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • Two Sigma Securities reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Securities sold 9,261 Exact Sciences shares in Q3 2024, an estimated $523K.
  • Two Sigma Securities first reported a position in Exact Sciences in Q2 2017 and held it in 9 quarters.
  • Two Sigma Securities's Exact Sciences position peaked at $1.27M in Q1 2024.
  • 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.